期刊论文详细信息
Immunity & Ageing
Does aging affect the immune status? A comparative analysis in 300 healthy volunteers from France, Austria and Spain
Adrien Rossary1  Edmond Rock1  Brigitte Winklhofer-Roob3  Josep Ribalta4  Jérémie Talvas1  Nicolas Goncalves-Mendes1  Marie-Chantal Farges1  Marie-Paule Vasson2 
[1] INRA, UMR, 1019, Equipes ECREIN & MICROCARD, CRNH Auvergne, F-63009, Clermont-Ferrand, France;Centre Jean Perrin, CHU Clermont-Ferrand, Service de Nutrition, F-63000, Clermont-Ferrand, France;Human Nutrition & Metabolism Research and Training Center (HNMRC), Institute of Molecular Biosciences, Karl-Franzens University, Graz, Austria;Unitat de Recerca en Lípids i Arteriosclerosi, Facultat de Medicina, Hospital Universitari de Sant Joan de Reus, Universitat Rovira i Virgili, Institut d’Investigació Sanitària Pere Virgili, CIBERDEM, Reus, Spain
关键词: Europe;    Immune status;    Aging;   
Others  :  814191
DOI  :  10.1186/1742-4933-10-38
 received in 2013-03-14, accepted in 2013-08-11,  发布年份 2013
PDF
【 摘 要 】

Background

As the European population is getting older, there is growing need in scientific data on how to achieve healthy and successful aging. A decline in immune function with age is unanimously supported by many epidemiological and clinical observations, with a decrease in T-cell mediated function encompassing a large part of this alteration. In the EU-funded VITAGE project, the effects of aging on biomarkers of immune status are being studied in three European countries. According to strict inclusion/exclusion criteria, a cohort of 300 healthy male non-smoking 20–75 years old volunteers were enrolled in France (n = 99), Spain (n = 100) and Austria (n = 101). In each country, the volunteers were classified as a function of age (one age group per decade). Biomarkers of immune status were determined including delayed-type hypersensitivity tests, measurement of lymphocyte surface markers, and serum determinations of interleukin-2, complement fractions and immunoglobulins.

Results

There were moderate differences in the biomarkers of immune status of the VITAGE study volunteers among the three European centres. The percentage of Natural Killer (NK) cells was 156% and 142% higher in Spain as compared to France and Austria, respectively (p < 0.0001), and this increase was observed at any age group above 30 years. Comparison between age-groups showed that in Spain, but not in France or Austria, older individuals had significantly a lower B lymphocyte distribution and conversely, a higher NK cell distribution. Moreover, the CD4/CD8 ratio was positively correlated with age in Austrian subjects (p < 0.0001).

Conclusion

Our results provide evidence of an increased NK cell distribution in the elderly, especially in the Spanish population. NK cell status may predict morbidity and mortality in the elderly, emphasizing the importance of innate as well as adaptive immunity in ensuring healthy longevity and cancer resistance, possibly in link with the Mediterranean diet.

【 授权许可】

   
2013 Vasson et al.; licensee BioMed Central Ltd.

【 预 览 】
附件列表
Files Size Format View
20140710025343459.pdf 1441KB PDF download
Figure 5. 64KB Image download
Figure 4. 48KB Image download
Figure 3. 27KB Image download
Figure 2. 41KB Image download
Figure 1. 50KB Image download
【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

Figure 5.

【 参考文献 】
  • [1]Rowe JW, Kahn RL: Human aging: usual and successful. Science 1987, 237:143-149.
  • [2]DelaRosa O, Pawelec G, Peralbo E, Wikby A, Mariani E, Mocchegiani E, Tarazona R, Solana R: Immunological biomarkers of ageing in man: changes in both innate and adaptive immunity are associated with health and longevity. Biogerontology 2006, 7:471-481.
  • [3]Mahbub S, Brubaker AL, Kovacs EJ: Aging of the innate immune system: an update. Curr Immunol Rev 2011, 7:104-115.
  • [4]Rea IM: BELFAST nonagenarians: nature or nurture? immunological, cardiovascular and genetic factors. Immun Ageing 2010, 7:6. BioMed Central Full Text
  • [5]Kaszubowska L, Dettlaff-Pokora A, Hak L, Szarynska M, Ryba M, Mysliwska J, Mysliwski A: Successful ageing of nonagenarians is related to the sensitivity of NK cells to activation. J Physiol Pharmacol 2008, 59(9):187-199.
  • [6]Mocchegiani E, Malavolta M: NK and NKT cell functions in immunosenescence. Aging Cell 2004, 3:177-184.
  • [7]Mocchegiani E, Giacconi R, Cipriano C, Malavolta M: NK and NKT cells in aging and longevity: role of zinc and metallothioneins. J Clin Immunol 2009, 29:416-425.
  • [8]Burns EA: Effects of aging on immune function. J Nutr Health Aging 2004, 8:9-18.
  • [9]Walrand S, Moreau K, Caldefie F, Tridon A, Chassagne J, Portefaix G, Cynober L, Beaufrère B, Vasson MP, Boirie Y: Specific and nonspecific immune responses to fasting and refeeding differ in healthy young adult and elderly persons. Am J Clin Nutr 2001, 74:670-678.
  • [10]Walrand S, Guillet C, Boirie Y, Vasson M-P: Insulin differentially regulates monocyte and polymorphonuclear neutrophil functions in healthy young and elderly humans. J Clin Endocrinol Metab 2006, 91:2738-2748.
  • [11]Brtko J, Rock E, Nezbedova P, Krizanova O, Dvorcakova M, Minet-Quinard R, Farges M-C, Ribalta J, Winklhofer-Roob BM, Vasson M-P, Macejova D: Age-related change in the retinoid X receptor beta gene expression in peripheral blood mononuclear cells of healthy volunteers: effect of 13-cis retinoic acid supplementation. Mech Ageing Dev 2007, 128:594-600.
  • [12]Minet-Quinard R, Farges MC, Thivat E, Deleine C, Mayot G, Brtko J, Ribalta J, Winklhofer-Roob B, Rock E, Vasson MP: Neutrophils are immune cells preferentially targeted by retinoic acid in elderly subjects. Immun Ageing 2010, 7:10. BioMed Central Full Text
  • [13]Farges M-C, Minet-Quinard R, Walrand S, Thivat E, Ribalta J, Winklhofer-Roob B, Rock E, Vasson M-P: Immune status is more affected by age than by carotenoid depletion-repletion in healthy human subjects. Br J Nutr 2012, 108:2054-2065.
  • [14]Licastro F, Candore G, Lio D, Porcellini E, Colonna-Romano G, Franceschi C, Caruso C: Innate immunity and inflammation in ageing: a key for understanding age-related diseases. Immun Ageing 2005, 2:8. BioMed Central Full Text
  • [15]Huang H, Patel DD, Manton KG: The immune system in aging: roles of cytokines, T cells and NK cells. Front Biosci 2005, 10:192-215.
  • [16]Solana R, Pawelec G, Tarazona R: Aging and innate immunity. Immunity 2006, 24:491-494.
  • [17]Derhovanessian E, Solana R, Larbi A, Pawelec G: Immunity, ageing and cancer. Immun Ageing 2008, 5:11. BioMed Central Full Text
  • [18]Ligthart GJ, Corberand JX, Fournier C, Galanaud P, Hijmans W, Kennes B, Müller-Hermelink HK, Steinmann GG: Admission criteria for immunogerontological studies in man: the SENIEUR protocol. Mech Ageing Dev 1984, 28:47-55.
  • [19]Lee DM, O’Neill TW, Pye SR, Silman AJ, Finn JD, Pendleton N, Tajar A, Bartfai G, Casanueva F, Forti G, Giwercman A, Huhtaniemi IT, Kula K, Punab M, Boonen S, Vanderschueren D, Wu FCW: The European male ageing study (EMAS): design, methods and recruitment. Int J Androl 2009, 32:11-24.
  • [20]Knoops KTB, De Groot LCPGM, Kromhout D, Perrin A-E, Moreiras-Varela O, Menotti A, Van Staveren WA: Mediterranean diet, lifestyle factors, and 10-year mortality in elderly European men and women: the HALE project. JAMA 2004, 292:1433-1439.
  • [21]Franceschi C, Bezrukov V, Blanché H, Bolund L, Christensen K, De Benedictis G, Deiana L, Gonos E, Hervonen A, Yang H, Jeune B, Kirkwood TBL, Kristensen P, Leon A, Pelicci PG, Peltonen L, Poulain M, Rea IM, Remacle J, Robine JM, Schreiber S, Sikora E, Slagboom PE, Spazzafumo L, Stazi MA, Toussaint O, Vaupel JW: Genetics of healthy aging in Europe: the EU-integrated project GEHA (GEnetics of Healthy Aging). Ann N Y Acad Sci 2007, 1100:21-45.
  • [22]Azais-Braesco V, Winklhoffer-Roob B, Ribalta J, Hanley B, Vasson MP, Brtko J, Brigeluis-Flohe R, Bronner A: Vitamin A, vitamin E and carotenoid status and metabolism during ageing: functional and nutritional consequences (project proposal). Endocr Regul 2000, 34:97-98.
  • [23]Rock E, Winklhofer-Roob BM, Ribalta J, Scotter M, Vasson MP, Brtko J, Brigelius-Flohe R, Bronner A, Azaïs-Braesco V: Vitamin A, vitamin E and carotenoid status and metabolism during ageing: functional and nutritional consequences (VITAGE PROJECT). Nutr Metab Cardiovasc Dis 2001, 11:70-73.
  • [24]Winklhofer-Roob BM, Roob JM, Maritschnegg M, Sprinz G, Hiller D, Marktfelder E, Preinsberger M, Wuga S, Sundl I, Tiran B, Cardinault N, Ribalta J, Rock E: Does aging affect the response of vitamin E status to vitamin E depletion and supplementation? Ann N Y Acad Sci 2004, 1031:381-384.
  • [25]Winklhofer-Roob BM, Meinitzer A, Maritschnegg M, Roob JM, Khoschsorur G, Ribalta J, Sundl I, Wuga S, Wonisch W, Tiran B, Rock E: Effects of vitamin E depletion/repletion on biomarkers of oxidative stress in healthy aging. Ann N Y Acad Sci 2004, 1031:361-364.
  • [26]Gameiro C, Romao F: Changes in the immune system during menopause and aging. Front Biosci (Elite Ed) 2010, 2:1299-1303.
  • [27]Carson PJ, Nichol KL, O’Brien J, Hilo P, Janoff EN: Immune function and vaccine responses in healthy advanced elderly patients. Arch Intern Med 2000, 160:2017-2024.
  • [28]Denham E, Mohn B, Tucker L, Lun A, Cleave P, Boswell DR: Evaluation of immunoturbidimetric specific protein methods using the Architect ci8200: comparison with immunonephelometry. Ann Clin Biochem 2007, 44:529-536.
  • [29]Kniker WT, Anderson CT, McBryde JL, Roumiantzeff M, Lesourd B: Multitest CMI for standardized measurement of delayed cutaneous hypersensitivity and cell-mediated immunity. Normal values and proposed scoring system for healthy adults in the USA. Ann Allergy 1984, 52(2):75-82.
  • [30]Sansoni P, Cossarizza A, Brianti V, Fagnoni F, Snelli G, Monti D, Marcato A, Passeri G, Ortolani C, Forti E: Lymphocyte subsets and natural killer cell activity in healthy old people and centenarians. Blood 1993, 82:2767-2773.
  • [31]Hazeldine J, Hampson P, Lord JM: Reduced release and binding of perforin at the immunological synapse underlies the age-related decline in natural killer cell cytotoxicity. Aging Cell 2012, 11:751-759.
  • [32]Wu J, Li W, Liu Z, Zhang Y-Y, Peng Y, Feng D-G, Li L-H, Wang L-N, Liu L, Li L, Liu J: Ageing-associated changes in cellular immunity based on the SENIEUR protocol. Scand J Immunol 2012, 75:641-646.
  • [33]Borrego F, Alonso MC, Galiani MD, Carracedo J, Ramirez R, Ostos B, Peña J, Solana R: NK phenotypic markers and IL2 response in NK cells from elderly people. Exp Gerontol 1999, 34:253-265.
  • [34]Ogata K, Yokose N, Tamura H, An E, Nakamura K, Dan K, Nomura T: Natural killer cells in the late decades of human life. Clin Immunol Immunopathol 1997, 84:269-275.
  • [35]Solana R, Mariani E: NK and NK/T cells in human senescence. Vaccine 2000, 18:1613-1620.
  • [36]Ogata K, An E, Shioi Y, Nakamura K, Luo S, Yokose N, Minami S, Dan K: Association between natural killer cell activity and infection in immunologically normal elderly people. Clin Exp Immunol 2001, 124:392-397.
  • [37]Sansoni P, Vescovini R, Fagnoni F, Biasini C, Zanni F, Zanlari L, Telera A, Lucchini G, Passeri G, Monti D, Franceschi C, Passeri M: The immune system in extreme longevity. Exp Gerontol 2008, 43:61-65.
  • [38]Mortality and life expectancy statistics. http://epp.eurostat.ec.europa.eu/statistics_explained/index.php/mortality_and_life_expectancy_statistics webcite, consulted in June 2013
  • [39]Leonardi GS, Houthuijs D, Steerenberg PA, Fletcher T, Armstrong B, Antova T, Lochman I, Lochmanová A, Rudnai P, Erdei E, Musial J, Jazwiec-Kanyion B, Niciu EM, Durbaca S, Fabiánová E, Koppová K, Lebret E, Brunekreef B, Van Loveren H: Immune biomarkers in relation to exposure to particulate matter: a cross-sectional survey in 17 cities of Central Europe. Inhal Toxicol 2000, 12(Suppl 4):1-14.
  • [40]Agudo A, Amiano P, Barcos A, Barricarte A, Beguiristain JM, Chirlaque MD, Dorronsoro M, González CA, Lasheras C, Martínez C, Navarro C, Pera G, Quirós JR, Rodríguez M, Tormo MJ: Dietary intake of vegetables and fruits among adults in five regions of Spain. EPIC Group of Spain. European Prospective Investigation into Cancer and Nutrition. Eur J Clin Nutr 1999, 53:174-180.
  • [41]Lasheras C, Fernandez S, Patterson AM: Mediterranean diet and age with respect to overall survival in institutionalized, nonsmoking elderly people. Am J Clin Nutr 2000, 71:987-992.
  • [42]Bamia C, Orfanos P, Ferrari P, Overvad K, Hundborg HH, Tjønneland A, Olsen A, Kesse E, Boutron-Ruault M-C, Clavel-Chapelon F, Nagel G, Boffetta P, Boeing H, Hoffmann K, Trichopoulos D, Baibas N, Psaltopoulou T, Norat T, Slimani N, Palli D, Krogh V, Panico S, Tumino R, Sacerdote C, Bueno-de-Mesquita HB, Ocké MC, Peeters PH, Van Rossum CT, Quirós J-R, Sánchez M-J, Navarro C, Barricarte A, Dorronsoro M, Berglund G, Wirfält E, Hallmans G, Johansson I, Bingham S, Khaw K-T, Spencer EA, Roddam AW, Riboli E, Trichopoulou A: Dietary patterns among older Europeans: the EPIC-Elderly study. Br J Nutr 2005, 94:100-113.
  • [43]Dean M, Raats MM, Grunert KG, Lumbers M: Factors influencing eating a varied diet in old age. Public Health Nutr 2009, 12:2421-2427.
  • [44]Trichopoulou A, Orfanos P, Norat T, Bueno-de-Mesquita B, Ocké MC, Peeters PHM, Van der Schouw YT, Boeing H, Hoffmann K, Boffetta P, Nagel G, Masala G, Krogh V, Panico S, Tumino R, Vineis P, Bamia C, Naska A, Benetou V, Ferrari P, Slimani N, Pera G, Martinez-Garcia C, Navarro C, Rodriguez-Barranco M, Dorronsoro M, Spencer EA, Key TJ, Bingham S, Khaw K-T, Kesse E, Clavel-Chapelon F, Boutron-Ruault M-C, Berglund G, Wirfalt E, Hallmans G, Johansson I, Tjonneland A, Olsen A, Overvad K, Hundborg HH, Riboli E, Trichopoulos D: Modified Mediterranean diet and survival: EPIC-elderly prospective cohort study. BMJ 2005, 330:991.
  • [45]Trichopoulou A, Dilis V: Olive oil and longevity. Mol Nutr Food Res 2007, 51:1275-1278.
  • [46]Roman B, Carta L, Martínez-González MA, Serra-Majem L: Effectiveness of the Mediterranean diet in the elderly. Clin Interv Aging 2008, 3:97-109.
  • [47]Mena M-P, Sacanella E, Vazquez-Agell M, Morales M, Fitó M, Escoda R, Serrano-Martínez M, Salas-Salvadó J, Benages N, Casas R, Lamuela-Raventós RM, Masanes F, Ros E, Estruch R: Inhibition of circulating immune cell activation: a molecular antiinflammatory effect of the Mediterranean diet. Am J Clin Nutr 2009, 89:248-256.
  • [48]Sofi F, Cesari F, Abbate R, Gensini GF, Casini A: Adherence to Mediterranean diet and health status: meta-analysis. BMJ 2008, 337:a1344.
  • [49]Mariani E, Meneghetti A, Formentini I, Neri S, Cattini L, Ravaglia G, Forti P, Facchini A: Telomere length and telomerase activity: effect of ageing on human NK cells. Mech Ageing Dev 2003, 124:403-408.
  • [50]Paganelli R, Quinti I, Fagiolo U, Cossarizza A, Ortolani C, Guerra E, Sansoni P, Pucillo LP, Scala E, Cozzi E: Changes in circulating B cells and immunoglobulin classes and subclasses in a healthy aged population. Clin Exp Immunol 1992, 90:351-354.
  • [51]Ginaldi L, De Martinis M, D’Ostilio A, Marini L, Loreto MF, Corsi MP, Quaglino D: The immune system in the elderly: I. Specific humoral immunity. Immunol Res 1999, 20:101-108.
  • [52]Facchini A, Mariani E, Mariani AR, Papa S, Vitale M, Manzoli FA: Increased number of circulating Leu 11+ (CD 16) large granular lymphocytes and decreased NK activity during human ageing. Clin Exp Immunol 1987, 68:340-347.
  • [53]Vitale M, Zamai L, Neri LM, Galanzi A, Facchini A, Rana R, Cataldi A, Papa S: The impairment of natural killer function in the healthy aged is due to a postbinding deficient mechanism. Cell Immunol 1992, 145:1-10.
  • [54]Panda A, Arjona A, Sapey E, Bai F, Fikrig E, Montgomery RR, Lord JM, Shaw AC: Human innate immunosenescence: causes and consequences for immunity in old age. Trends Immunol 2009, 30:325-333.
  • [55]Lesourd BM, Meaume S: Cell mediated immunity changes in ageing, relative importance of cell subpopulation switches and of nutritional factors. Immunol Lett 1994, 40:235-242.
  • [56]Blank PR, Schwenkglenks M, Szucs TD: Vaccination coverage rates in eleven European countries during two consecutive influenza seasons. J Infect 2009, 58:446-458.
  • [57]Endrich MM, Blank PR, Szucs TD: Influenza vaccination uptake and socioeconomic determinants in 11 European countries. Vaccine 2009, 27:4018-4024.
  • [58]Trnka L, Dankova D, Zitova J, Cimprichova L, Migliori GB, Clancy L, Zellweger JP: Survey of BCG vaccination policy in Europe: 1994–96. Bull World Health Organ 1998, 76:85-91.
  • [59]Bas E, Recio MC, Giner RM, Máñez S, López-Ginés C, Gil-Benso R, Ríos JL: Demethylnobiletin inhibits delayed-type hypersensitivity reactions, human lymphocyte proliferation and cytokine production. Br J Pharmacol 2007, 152:1272-1282.
  • [60]Poulter LW, Seymour GJ, Duke O, Janossy G, Panayi G: Immunohistological analysis of delayed-type hypersensitivity in man. Cell Immunol 1982, 74:358-369.
  • [61]Venkataraman M, Rao DS, Westerman MP: Functional studies on long-term cryopreserved peripheral blood mononuclear cells from patients with lung cancer and from healthy subjects. J Lab Clin Med 1992, 120:453-458.
  • [62]Schulz JC, Germann A, Kemp-Kamke B, Mazzotta A, von Briesen H, Zimmermann H: Towards a xeno-free and fully chemically defined cryopreservation medium for maintaining viability, recovery, and antigen-specific functionality of PBMC during long-term storage. J Immunol Methods 2012, 382:24-31.
  文献评价指标  
  下载次数:12次 浏览次数:15次